Germany
Japan
United Kingdom
China
Antibodies
View as table Download
USD 450.00
In Stock
Mouse monoclonal ACE2 Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 450.00
5 Days
Mouse monoclonal NR3C1 Antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Mouse monoclonal ERCC1 Antibody (C-term)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse monoclonal HDAC1 Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse Monoclonal anti-Tubulin-alpha Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat and All Species |
| Conjugation | Unconjugated |
Mouse Monoclonal Tirap Antibody (20D1055.1)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse monoclonal Anti-BORIS Clone 4A7
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse Monoclonal B3GAT1 (CD57) Antibody
| Applications | IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-alpha-gal epitope (Clone m86)
| Applications | ELISA, FC |
| Conjugation | Unconjugated |
| Modifications | This chimeric human antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-GM2 ganglioside (Clone L55-81)
| Applications | ELISA, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-desmosome/hemidesmosome (Clone F12)
| Applications | IF |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-Lewis a,b (Clone HEA164)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD15 (Clone BRA-4F1)
| Applications | FC, IF, IHC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD36 (Clone 185-1G2 (B467))
| Applications | Bl, FC, IF, IHC, IP |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD59 (Clone 193-27)
| Applications | FC, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
| Applications | ELISA, IF |
| Conjugation | Unconjugated |
| Modifications | This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
USD 675.00
2 Weeks
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3018 (03-018))
| Applications | ELISA, IF |
| Reactivities | SARS-CoV |
| Conjugation | Unconjugated |
| Modifications | This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
USD 675.00
2 Weeks
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
| Applications | ELISA, IF |
| Reactivities | SARS-CoV |
| Conjugation | Unconjugated |
| Modifications | This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Active filters
Isotypes
- IgM, kappa
Filter by
Category
Target Symbol
Reactivities
Antibody Hosts
Clonalities
Conjugates
Modifications
- This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Families
Pathways
- Metabolic pathways (2)
- Pathways in cancer (2)
- Adherens junction (1)
- Alzheimer's disease (1)
- Cell cycle (1)
- Chondroitin sulfate biosynthesis (1)
- Chronic myeloid leukemia (1)
- Endocytosis (1)
- Gap junction (1)
- Glycolysis / Gluconeogenesis (1)
- Heparan sulfate biosynthesis (1)
- Huntington's disease (1)
- Neuroactive ligand-receptor interaction (1)
- Notch signaling pathway (1)
- Nucleotide excision repair (1)
- Pathogenic Escherichia coli infection (1)
- Renin-angiotensin system (1)
- Thyroid cancer (1)
- Toll-like receptor signaling pathway (1)